BCR-ABL-transformed GMP as myeloid leukemic stem cells

87Citations
Citations of this article
65Readers
Mendeley users who have this article in their library.

Abstract

During blast crisis of chronic myelogenous leukemia (CML), abnormal granulocyte macrophage progenitors (GMP) with nuclear β-catenin acquire self-renewal potential and may function as leukemic stem cells (Jamieson et al. N Engl J Med, 2004). To develop a mouse model for CML-initiating GMP, we expressed p210BCR-ABL in an established line of E2A-knockout mouse BM cells that retain pluripotency in ex vivo culture. Expression of BCR-ABL in these cells reproducibly stimulated myeloid expansion in culture and generated leukemia-initiating cells specifically in the GMP compartment. The leukemogenic GMP displayed higher levels of β-catenin activity than either the nontransformed GMP or the transformed nonGMP, both in culture and in transplanted mouse BM. Although E2A-deficiency may have contributed to the formation of leukemogenic GMP, restoration of E2A-function did not reverse BCR-ABL-induced transformation. These results provide further evidence that BCR-ABL-transformed GMP with abnormal β-catenin activity can function as leukemic stem cells. © 2008 by The National Academy of Sciences of the USA.

Cite

CITATION STYLE

APA

Minami, Y., Stuart, S. A., Ikawa, T., Jiang, Y., Banno, A., Hunton, I. C., … Wang, J. Y. J. (2008). BCR-ABL-transformed GMP as myeloid leukemic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 105(46), 17967–17972. https://doi.org/10.1073/pnas.0808303105

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free